mRNA |
BRD-K33514849 |
CTRPv2 |
pan-cancer |
AAC |
-0.0013 |
1 |
mRNA |
BRD-K64610608 |
CTRPv2 |
pan-cancer |
AAC |
0.00041 |
1 |
mRNA |
AKT inhibitor VIII |
GDSC1000 |
pan-cancer |
AAC |
0.00035 |
1 |
mRNA |
MST-312 |
CTRPv2 |
pan-cancer |
AAC |
-0.00032 |
1 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.00033 |
1 |
mRNA |
Talazoparib |
GDSC1000 |
pan-cancer |
AAC |
0.00028 |
1 |
mRNA |
YM-155 |
GDSC1000 |
pan-cancer |
AAC |
-0.00028 |
1 |
mRNA |
BRD-K45681478 |
CTRPv2 |
pan-cancer |
AAC |
0.00028 |
1 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.00017 |
1 |
mRNA |
BRD-K94991378 |
CTRPv2 |
pan-cancer |
AAC |
-0.00011 |
1 |